Balaji Amines Ltd

Know More
NSEBSE

2221.20-16.85 (-0.75%)

11:09 AM,26th Feb 2024

2221.10-13.15 (-0.59%)

11:21 AM,26th Feb 2024

BSE : 530999

NSE : BALAMINES

Sector : Industrials

ISIN Code : INE050E01027

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Feb 26 2024 | 11:21 AM IST

Market Cap (₹ Cr)

7196

Turnover (₹ Cr)

0.60

Volume (Shares)

27236

Face Value

2

52-WK High

2735.00

52-WK High Date

01 Jan 2024

52-WK Low

1880.00

52-WK Low Date

22 May 2023

All Time High

5223.55

All Time High Date

15 Sep 2021

All Time Low

9.26

All Time Low Date

18 Feb 2009

Balaji Amines Ltd

Promoted by the KPR Group of Industries Balaji Amines Ltd. (BAL) was incorporated on 27th October 1988. The Company is a leading manufacturer of ethyl and methyl amines which have various applications in chemical industries. It is presently engaged in manufacture and sale of Speciality Chemicals Aliphatic Amines and derivatives. Apart from this it has now diversified into producing derivatives of methyl and ethyl amines namely Di-Methyl Amine Hydrochloride (DMA-HCl) Choline Chloride Di Methyl Acetamide etc. At present the Company supply to various Blue Chip Companies like IDI Hoechst Rallis Ion Exchange Cheminor Drugs TTK Pharma etc. It has four manufacturing facilities three plants at Tuljapur and Chincholi in Maharashtra and one at Medak Telangana. It owns a Five Star Hotel in Solapur Maharashtra and has CFL lamps facility at Medak Telangana. The Company presently operates in three segments i.e. Specialty Chemicals and Amines Hotel and CFL Lamps. A new facility for manufacture of Speciality Chemicals is under construction at Chicholi Maharashtra.On May '95 it came out with a public issue of 9.63 lac equity shares (premium : Rs 30) aggregating Rs 3.85 cr to part-finance expansion plans for ethylamines and forward integration for the manufacture of derivatives of methyl and ethyl amines totaling to Rs 10 cr. In 1988 the Company started business operations.In 1989 it started to produce Methyl Amines and Ethyl Amines.In 1992 the Company established R&D Centre at Hyderabad.In 1995 it started manufacturing drug intermediate -Dimethyl Amine Hydrochloride.In 1997-98 the company has successfully commenced the commercial operation of its main plant (Ethyl Amines) from June 1997.In 2000 it added derivatives of Methyl and Ethyle Amines to the product portfolio.In 2001 the Company was certified with ISO:9001.Expansion programme has been taken up for value-added products like Choline Chloride DMAE-HCI and other intermediates at a cost of Rs.500 lacs. The project has been appraised by State Bank of Hyderabad and Bank of India for a term loan of Rs.290 lacs and Rs.100 lacs respectively.The balance would be met out by the internal accruals of the company.The project would be implemented on phases and the first phase is likely to be commissioned during the current year 2001-2002.During the year 2003 Company was awarded Recognized Export House status from Government of India Ministry of Commerce New Delhi. It increased the capacity of Methyl Amines.In 2005 the Company developed more specialty chemicals.In 2006 it founded Balaji Foundation and Research Centre for the rural population as a part of CSR activity. It became the sole manufacturerof GBI NMP and Morpholine.During the year 2009 the Company started power generation through windmill by establishing 1.5 MW windmill unit at Satara Maharashtra. It established an R & D GBL Plant at Tamalwadi Solapur. It commenced setting up 2.5 MW Co-Generation Power Plant Unit at Tamalwadi and PVP Plant at Chincholi in Solapur respectively. Apart from this it secured the `Certificate of Merit' for Outstanding Export by Chemexcil.During the year 2010 2.5 Mw Co- Generation Power Plant at Tamalwadi Solapur has been commissioned in July 2009. Besides this the PVP Plant at Chincholi Solapur has started producing various grades and the mandatory approvals are in final stages.In 2010 the Company installed wind turbine for generating in-house electricity to start focusing on renewable energy.In 2012 the Company received Certificate of Suitability certification from European Directorate for the Quality Medicines & Health Care (EDQM) Europe for its product PVPK-30. It also received WHOGMP certification and REACH (Registration Evaluation Authorization and Restriction of Chemicals) for four products namely Triethylamine Gammabutyrolactone N-Ethylamine-2-Pyrrolidone along with the already registered N-methyl 2 Pyrrolidone (NMP). It has been awarded for the category of Best Manufacturer - Exporter (Medium) at the `Indian Exporter Excellence Awards 2012 instituted by the Export Credit Guarantee Corporation of India Limited (ECGC)[An Indian Govt. Undertaking] in association with Dun and Bradstreet (D&B) which seeks to recognize leading exporters for their excellence in their respective fields. In October 2013 the Company inaugurated its 129 Room Five-Star Hotel Property `Balaji Sarovar Premiere' with an investment of Rs. 110 crore. It executed the commissioning of DMF manufacturing Plant. Further two new plants one for the first phase of Di-Methyl Amine Hydrochloride (DMA-HCL) with an installed capacity of 7500 MT per annum commissioned in the month of February 2013 and second plant for manufacture of Di Methyl Formamide (DMF) with an installed capacity of 30000 MT / P. A at MIDC Chincholi Solapur has been commissioned in the month of March 2013. During the year 2013 Company's 5 star Hotel Property started commercially from 1st November 2013 which is being managed by Sarovar Group of Hotels.In 2014 the Company was awarded for Balaji Sarovar Premium's `eco-friendly Green technology'.During the year 2015 Company successfully re-commissioned its DMF plant by strengthening the Carbon Monoxide plan. In 2015 it was awarded another `Certificate of Excellence' for Balaji Sarovar Premiere from the `Trip Advisor `on the basis of customer reviews for excellent food service and hospitality.In 2016 it set up a plant to manufacture Acetonitrile.During the year 2017-18 the subsidiaries of the Company viz. Bhagyanagar Chemicals Limited (company's holding 100%) and Balaji Greentech Products Limited (company's holding 66%) were amalgamated with BAL (the Company) as per the scheme of amalgamation sanctioned by the Hon'ble NCLT Mumbai.In 2018 the Company was 90 acres of land at MIDC Chincholi with Mega Project Status for this new project by Maharashtra State Government. It commissioned a new plant for manufacture of Morpholine and Acetonitrile after successful trial runs.In 2019 the Company set up a new plant under subsidiary Balaji Specialty Chemicals Private Limited. The project was completed in a record 12 months and received Environment Clearance for Greenfield Project as well. It received Environmental Clearance for Balaji Amines Unit- IV Greenfield Project.In 2021 Company commenced operation in Greenfield Project at Unit-IV.

Balaji Amines Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

7196

EPS - TTM (₹) [S]

45.19

P/E Ratio (X) [S]

5.02

Face Value (₹) 2
Latest Dividend (%)500.00
Latest Dividend Date 03 Jul 2023
Dividend Yield (%) 0.45
Book Value Share (₹) [S]442.60
P/B Ratio (₹) [S]5.02
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)
Groww Nifty Total Market Index Fund-Regular (G) 0.01 63 0.01
Groww Nifty Total Market Index Fund-Direct (G) 0.01 63 0.01

Research Reports

Date BrokerActionPrices(Rs)Report
03-11-2022Edelweiss Buy 3004
31-03-2022Edelweiss Research Buy 2925

Stock Strength

Today's Low/High

2205.00

2259.00

Week Low/High

2205.00

2345.00

Month Low/High

2141.80

2495.00

Year Low/High

1880.00

2735.00

All time Low/High

1.56

5224.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-2.98%-3.05%0.150.05%
1 Month-6.07%-6.14%3.003.65%
3 Month9.96%9.99%10.3811.81%
6 Month4.30%4.41%12.2314.88%
1 Year2.99%3.04%22.4626.72%
3 Year36.30%36.34%48.3152.33%

Company Info

Company Information

Executive Chairman : A Prathap Reddy

Joint Managing Director : N Rajeshwar Reddy

Managing Director : D Ram Reddy

Whole Time Director & CFO : A Srinivas Reddy

Company Sec. & Compli. Officer : Lakhan Suganchand Dargad

Independent Director : Suhasini Y Shah

Independent Director : Adabala Seshagiri Rao

Independent Director : Uma Rajiv Pradhan

Independent Director : R. Mohan Kumar

Registered Office: Balaji Towers No 9/1A/1, Hotgi Road Aasara Chowk,Solapur,Maharashtra-413224 Ph: 91-217-2310824

Email:cs@balajiamines.com

URL:http://www.balajiamines.com